iifl-logo

Balaxi Pharmaceuticals Ltd Share Price Live

50.05
(0.14%)
Jun 27, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open50.15
  • Day's High54.7
  • 52 Wk High129.44
  • Prev. Close49.98
  • Day's Low49.95
  • 52 Wk Low 48.73
  • Turnover (lac)565.37
  • P/E77
  • Face Value2
  • Book Value23.16
  • EPS0.65
  • Mkt. Cap (Cr.)276.31
  • Div. Yield0
View All Historical Data
No Records Found

Balaxi Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

50.15

Prev. Close

49.98

Turnover(Lac.)

565.37

Day's High

54.7

Day's Low

49.95

52 Week's High

129.44

52 Week's Low

48.73

Book Value

23.16

Face Value

2

Mkt Cap (₹ Cr.)

276.31

P/E

77

EPS

0.65

Divi. Yield

0

Balaxi Pharmaceuticals Ltd Corporate Action

31 Jul 2024

12:00 AM

AGM

Announcement Date: 31 Jul, 2024

arrow

21 May 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

Balaxi Pharmaceuticals Ltd NEWS AND UPDATE

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Balaxi Pharmaceuticals Ltd SHAREHOLDING SNAPSHOT

28 Jun, 2025|03:32 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 65.99%

Foreign: 0.00%

Indian: 65.99%

Non-Promoter- 16.04%

Institutions: 16.04%

Non-Institutions: 17.96%

Custodian: 0.00%

Share Price

Balaxi Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2024Mar-2023Mar-2022Mar-2021

Equity Capital

14.67

20.48

10

10

Preference Capital

0

0

0

0

Reserves

106.88

71.63

47.91

33.25

Net Worth

121.55

92.11

57.91

43.25

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Revenue

101.29

86.87

45.63

0

yoy growth (%)

16.59

90.37

0

0

Raw materials

-76.91

-63.32

-33.57

0

As % of sales

75.93

72.89

73.58

0

Employee costs

-2.89

-1.94

-1.76

-0.15

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2018

Profit before tax

19.69

20.59

9.26

-0.76

Depreciation

-0.25

-0.08

0

0

Tax paid

-5.03

-5.46

-2.76

0

Working capital

5.53

-0.38

25.39

-0.78

Other operating items

View Cash Flow
Y/e 31 MarMar-2022Mar-2021Mar-2020Mar-2018

Growth matrix (%)

Revenue growth

16.59

90.37

0

0

Op profit growth

-8.6

192.29

-941.06

471.3

EBIT growth

-4.12

122.43

-1,303.49

478.82

Net profit growth

-3.07

132.97

-943.73

341.95

View Ratios
Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

292.56

241.29

336.43

279.39

231.33

Excise Duty

0

0

0

0

0

Net Sales

292.56

241.29

336.43

279.39

231.33

Other Operating Income

0

0

0

0

0

Other Income

-3.72

-2.65

2.64

4.97

2.23

Balaxi Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,669.8

93.524,00,520.992,000.460.967,107.14101.44

Divis Laboratories Ltd

DIVISLAB

6,616

79.481,75,574.286670.452,536561.08

Cipla Ltd

CIPLA

1,513.8

25.391,22,1861,485.41.064,254.47397.41

Dr Reddys Laboratories Ltd

DRREDDY

1,321.5

20.611,10,263.531,200.70.615,546.3345.76

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,222.5

57.291,09,167.444740.992,385224.33

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Balaxi Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Managing Director

Ashish Maheshwari

Non Executive Director

Minoshi Maheshwari

Independent Non Exe. Director

Kunal M Bhakta

Independent Non Exe. Director

Gandhi Gamji

Independent Non Exe. Director

M. Srinivas Rao

Company Sec. & Compli. Officer

Mohith Kumar Khandelwal

Registered Office

41/298-D2 2nd Flr Saniya Plaza,

Mahakavi Bharatiyar Road,

Kerala - 682035

Tel: 91-484-4032952/6596725

Website: http://www.balaxipharma.in

Email: [email protected]

Registrar Office

Surya 35 Mayflower,

Avenue Sowripalayam, Road,

Coimbatore - 641 028

Tel: 91-422-4958995/836

Website: www.skdc-consultants.com

Email: [email protected]

Summary

Balaxi Ventures Limited was formerly incorporated in the name of The Anandam Rubber Company Limited on September 28, 1942. The Company changed its name from The Anandam Rubber Company Limited to Balax...
Read More

Company FAQs

What is the Balaxi Pharmaceuticals Ltd share price today?

The Balaxi Pharmaceuticals Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹50.05 today.

What is the Market Cap of Balaxi Pharmaceuticals Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Balaxi Pharmaceuticals Ltd is ₹276.31 Cr. as of 27 Jun ‘25

What is the PE and PB ratio of Balaxi Pharmaceuticals Ltd?

The PE and PB ratios of Balaxi Pharmaceuticals Ltd is 77 and 2.16 as of 27 Jun ‘25

What is the 52 Week High and Low of Balaxi Pharmaceuticals Ltd?

The 52-week high/low is the highest and lowest price at which a Balaxi Pharmaceuticals Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Balaxi Pharmaceuticals Ltd is ₹48.73 and ₹129.44 as of 27 Jun ‘25

What is the CAGR of Balaxi Pharmaceuticals Ltd?

Balaxi Pharmaceuticals Ltd's CAGR for 5 Years at 14.83%, 3 Years at -11.96%, 1 Year at -60.01%, 6 Month at -32.12%, 3 Month at -22.50% and 1 Month at -5.66%.

What is the shareholding pattern of Balaxi Pharmaceuticals Ltd?

The shareholding pattern of Balaxi Pharmaceuticals Ltd is as follows:
Promoters - 65.99 %
Institutions - 16.05 %
Public - 17.96 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.